Cargando…
Circulating autoantibodies against neuroblastoma suppressor of tumorigenicity 1 (NBL1): A potential biomarker for coronary artery disease in patients with obstructive sleep apnea
OBJECTIVE: Although severe obstructive sleep apnea (OSA) is an important risk factor for atherosclerosis-related diseases including coronary artery disease (CAD), there is no reliable biomarker of CAD risks in patients with OSA. This study aimed to test our hypothesis that circulating autoantibodies...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875805/ https://www.ncbi.nlm.nih.gov/pubmed/29596467 http://dx.doi.org/10.1371/journal.pone.0195015 |
_version_ | 1783310415962308608 |
---|---|
author | Matsumura, Takuma Terada, Jiro Kinoshita, Taku Sakurai, Yoriko Yahaba, Misuzu Tsushima, Kenji Sakao, Seiichiro Nagashima, Kengo Ozaki, Toshinori Kobayashi, Yoshio Hiwasa, Takaki Tatsumi, Koichiro |
author_facet | Matsumura, Takuma Terada, Jiro Kinoshita, Taku Sakurai, Yoriko Yahaba, Misuzu Tsushima, Kenji Sakao, Seiichiro Nagashima, Kengo Ozaki, Toshinori Kobayashi, Yoshio Hiwasa, Takaki Tatsumi, Koichiro |
author_sort | Matsumura, Takuma |
collection | PubMed |
description | OBJECTIVE: Although severe obstructive sleep apnea (OSA) is an important risk factor for atherosclerosis-related diseases including coronary artery disease (CAD), there is no reliable biomarker of CAD risks in patients with OSA. This study aimed to test our hypothesis that circulating autoantibodies against neuroblastoma suppressor of tumorigenicity 1 (NBL1-Abs) are associated with the prevalence of CAD in patients with OSA. METHODS: Eighty-two adults diagnosed with OSA by polysomnography, 96 patients with a diagnosis of acute coronary syndrome (ACS) and 64 healthy volunteers (HVs) were consecutively enrolled. Serum samples were collected from patients with OSA at diagnostic polysomnography and from patients with ACS at disease onset. Serum NBL1-Ab level was measured by amplified luminescence proximity homogeneous assay and its association with clinical variables related to atherosclerosis was evaluated. RESULTS: NBL1-Ab level was significantly elevated in patients with both OSA and ACS compared with HVs. Subgroup analyses showed that NBL1-Ab level was markedly higher in patients with severe OSA and OSA patients with a history of CAD. Weak associations were observed between NBL1-Ab level and apnea-hypopnea index, age, mean SpO(2) and arousal index, whereas significantly higher NBL1-Ab levels were observed in OSA patients with a history of CAD than in those without a history of CAD. Sensitivity analysis using a logistic regression model also demonstrated that increased NBL1-Ab levels were associated with the previous history of CAD in patients with OSA. CONCLUSIONS: Elevated NBL1-Ab levels may be associated with the prevalence of CAD in patients with OSA, which needs to be confirmed further. |
format | Online Article Text |
id | pubmed-5875805 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-58758052018-04-13 Circulating autoantibodies against neuroblastoma suppressor of tumorigenicity 1 (NBL1): A potential biomarker for coronary artery disease in patients with obstructive sleep apnea Matsumura, Takuma Terada, Jiro Kinoshita, Taku Sakurai, Yoriko Yahaba, Misuzu Tsushima, Kenji Sakao, Seiichiro Nagashima, Kengo Ozaki, Toshinori Kobayashi, Yoshio Hiwasa, Takaki Tatsumi, Koichiro PLoS One Research Article OBJECTIVE: Although severe obstructive sleep apnea (OSA) is an important risk factor for atherosclerosis-related diseases including coronary artery disease (CAD), there is no reliable biomarker of CAD risks in patients with OSA. This study aimed to test our hypothesis that circulating autoantibodies against neuroblastoma suppressor of tumorigenicity 1 (NBL1-Abs) are associated with the prevalence of CAD in patients with OSA. METHODS: Eighty-two adults diagnosed with OSA by polysomnography, 96 patients with a diagnosis of acute coronary syndrome (ACS) and 64 healthy volunteers (HVs) were consecutively enrolled. Serum samples were collected from patients with OSA at diagnostic polysomnography and from patients with ACS at disease onset. Serum NBL1-Ab level was measured by amplified luminescence proximity homogeneous assay and its association with clinical variables related to atherosclerosis was evaluated. RESULTS: NBL1-Ab level was significantly elevated in patients with both OSA and ACS compared with HVs. Subgroup analyses showed that NBL1-Ab level was markedly higher in patients with severe OSA and OSA patients with a history of CAD. Weak associations were observed between NBL1-Ab level and apnea-hypopnea index, age, mean SpO(2) and arousal index, whereas significantly higher NBL1-Ab levels were observed in OSA patients with a history of CAD than in those without a history of CAD. Sensitivity analysis using a logistic regression model also demonstrated that increased NBL1-Ab levels were associated with the previous history of CAD in patients with OSA. CONCLUSIONS: Elevated NBL1-Ab levels may be associated with the prevalence of CAD in patients with OSA, which needs to be confirmed further. Public Library of Science 2018-03-29 /pmc/articles/PMC5875805/ /pubmed/29596467 http://dx.doi.org/10.1371/journal.pone.0195015 Text en © 2018 Matsumura et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Matsumura, Takuma Terada, Jiro Kinoshita, Taku Sakurai, Yoriko Yahaba, Misuzu Tsushima, Kenji Sakao, Seiichiro Nagashima, Kengo Ozaki, Toshinori Kobayashi, Yoshio Hiwasa, Takaki Tatsumi, Koichiro Circulating autoantibodies against neuroblastoma suppressor of tumorigenicity 1 (NBL1): A potential biomarker for coronary artery disease in patients with obstructive sleep apnea |
title | Circulating autoantibodies against neuroblastoma suppressor of tumorigenicity 1 (NBL1): A potential biomarker for coronary artery disease in patients with obstructive sleep apnea |
title_full | Circulating autoantibodies against neuroblastoma suppressor of tumorigenicity 1 (NBL1): A potential biomarker for coronary artery disease in patients with obstructive sleep apnea |
title_fullStr | Circulating autoantibodies against neuroblastoma suppressor of tumorigenicity 1 (NBL1): A potential biomarker for coronary artery disease in patients with obstructive sleep apnea |
title_full_unstemmed | Circulating autoantibodies against neuroblastoma suppressor of tumorigenicity 1 (NBL1): A potential biomarker for coronary artery disease in patients with obstructive sleep apnea |
title_short | Circulating autoantibodies against neuroblastoma suppressor of tumorigenicity 1 (NBL1): A potential biomarker for coronary artery disease in patients with obstructive sleep apnea |
title_sort | circulating autoantibodies against neuroblastoma suppressor of tumorigenicity 1 (nbl1): a potential biomarker for coronary artery disease in patients with obstructive sleep apnea |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875805/ https://www.ncbi.nlm.nih.gov/pubmed/29596467 http://dx.doi.org/10.1371/journal.pone.0195015 |
work_keys_str_mv | AT matsumuratakuma circulatingautoantibodiesagainstneuroblastomasuppressoroftumorigenicity1nbl1apotentialbiomarkerforcoronaryarterydiseaseinpatientswithobstructivesleepapnea AT teradajiro circulatingautoantibodiesagainstneuroblastomasuppressoroftumorigenicity1nbl1apotentialbiomarkerforcoronaryarterydiseaseinpatientswithobstructivesleepapnea AT kinoshitataku circulatingautoantibodiesagainstneuroblastomasuppressoroftumorigenicity1nbl1apotentialbiomarkerforcoronaryarterydiseaseinpatientswithobstructivesleepapnea AT sakuraiyoriko circulatingautoantibodiesagainstneuroblastomasuppressoroftumorigenicity1nbl1apotentialbiomarkerforcoronaryarterydiseaseinpatientswithobstructivesleepapnea AT yahabamisuzu circulatingautoantibodiesagainstneuroblastomasuppressoroftumorigenicity1nbl1apotentialbiomarkerforcoronaryarterydiseaseinpatientswithobstructivesleepapnea AT tsushimakenji circulatingautoantibodiesagainstneuroblastomasuppressoroftumorigenicity1nbl1apotentialbiomarkerforcoronaryarterydiseaseinpatientswithobstructivesleepapnea AT sakaoseiichiro circulatingautoantibodiesagainstneuroblastomasuppressoroftumorigenicity1nbl1apotentialbiomarkerforcoronaryarterydiseaseinpatientswithobstructivesleepapnea AT nagashimakengo circulatingautoantibodiesagainstneuroblastomasuppressoroftumorigenicity1nbl1apotentialbiomarkerforcoronaryarterydiseaseinpatientswithobstructivesleepapnea AT ozakitoshinori circulatingautoantibodiesagainstneuroblastomasuppressoroftumorigenicity1nbl1apotentialbiomarkerforcoronaryarterydiseaseinpatientswithobstructivesleepapnea AT kobayashiyoshio circulatingautoantibodiesagainstneuroblastomasuppressoroftumorigenicity1nbl1apotentialbiomarkerforcoronaryarterydiseaseinpatientswithobstructivesleepapnea AT hiwasatakaki circulatingautoantibodiesagainstneuroblastomasuppressoroftumorigenicity1nbl1apotentialbiomarkerforcoronaryarterydiseaseinpatientswithobstructivesleepapnea AT tatsumikoichiro circulatingautoantibodiesagainstneuroblastomasuppressoroftumorigenicity1nbl1apotentialbiomarkerforcoronaryarterydiseaseinpatientswithobstructivesleepapnea |